Profit

Looking to More R&D Spend: Dilip Shanghvi

PUBLISHED ON: March 25, 2015 | Duration: 28 min, 27 sec

  
loading..
The Ranbaxy merger will help increase R&D spend and the combined entity is looking forward to spend 6-7 per cent of turnover in research, said Dilip Shanghvi, the MD of Sun Pharma.
ALSO WATCH
Exclusive: The Cash-For-'Bail' Tapes

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com